Medicare coverage

Tuebingen, Germany — August 26, 2026 HepaRegeniX GmbH announced that the U.S. FDA has granted Orphan Drug Designation (ODD)...

Lawrenceville, New Jersey – August 26, 2026 IMUNON announced plans to host its 2026 R&D Day on September 23...

Fort Myers, Florida – August 26, 2026 NeoGenomics announced that its RaDaR ST molecular residual disease (MRD) assay has...

Latham, New York | May 28, 2026 AngioDynamics announced that Palmetto GBA has issued a final Local Coverage Determination...

FREMONT, California, May 20, 2026 Personalis announced that the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program...

FAIRFAX, Va., January 22, 2026 — Re:Cognition Health announced that Medicare coverage is now available for FDA-approved amyloid-targeting therapies...